These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 31539692

  • 1. Using self-reported vocational functioning measures to identify employed patients with impaired functional capacity in major depressive disorder.
    Murthy NV, Xu R, Zhong W, Harvey PD.
    J Affect Disord; 2020 Jan 01; 260():550-556. PubMed ID: 31539692
    [Abstract] [Full Text] [Related]

  • 2. Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
    Christensen MC, Loft H, McIntyre RS.
    J Affect Disord; 2018 Feb 01; 227():787-794. PubMed ID: 29689693
    [Abstract] [Full Text] [Related]

  • 3. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
    Baune BT, Sluth LB, Olsen CK.
    J Affect Disord; 2018 Mar 15; 229():421-428. PubMed ID: 29331703
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder.
    Harvey PD, Jacobson W, Zhong W, Nomikos GG, Cronquist Christensen M, Kurre Olsen C, Merikle E.
    J Affect Disord; 2017 Apr 15; 213():105-111. PubMed ID: 28213121
    [Abstract] [Full Text] [Related]

  • 8. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
    Levada OA, Troyan AS.
    J Affect Disord; 2019 May 01; 250():114-122. PubMed ID: 30852363
    [Abstract] [Full Text] [Related]

  • 9. Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD).
    Chokka P, Bougie J, Rampakakis E, Proulx J.
    CNS Spectr; 2019 Jun 01; 24(3):338-347. PubMed ID: 29792585
    [Abstract] [Full Text] [Related]

  • 10. A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
    Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS.
    Neuropsychopharmacology; 2015 Jul 01; 40(8):2025-37. PubMed ID: 25687662
    [Abstract] [Full Text] [Related]

  • 11. Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study.
    Chokka P, Bougie J, Proulx J, Tvistholm AH, Ettrup A.
    CNS Spectr; 2019 Dec 01; 24(6):616-627. PubMed ID: 30802419
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
    McIntyre RS, Florea I, Tonnoir B, Loft H, Lam RW, Christensen MC.
    J Clin Psychiatry; 2017 Jan 01; 78(1):115-121. PubMed ID: 27780334
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Sampson E, Mills NT, Hori H, Schwarte K, Hohoff C, Schubert O, Clark SR, Fourrier C, Baune BT.
    J Clin Psychiatry; 2023 Oct 04; 84(6):. PubMed ID: 37796652
    [Abstract] [Full Text] [Related]

  • 17. Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.
    Christensen MC, Munro V.
    Curr Med Res Opin; 2018 Apr 04; 34(4):593-600. PubMed ID: 29235884
    [Abstract] [Full Text] [Related]

  • 18. Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine for Major Depressive Disorder: Findings From Placebo-Controlled Trials.
    Jordan JT, Shen L, Cooper NJ, Goncalves SV, Trivedi MH, Schatzberg AF, Wu W, Savitz AJ, Etkin A.
    J Clin Psychiatry; 2024 Sep 04; 85(4):. PubMed ID: 39240698
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.
    Subramaniapillai M, Mansur RB, Zuckerman H, Park C, Lee Y, Iacobucci M, Cao B, Ho R, Lin K, Phan L, McIntyre RS.
    Compr Psychiatry; 2019 Oct 04; 94():152113. PubMed ID: 31404802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.